Expression and Clinical Significance of CEA mRNA in Peripheral Blood of Non-small Cell Lung Cancer Patients
Kai Ding
Abstract
Kai Ding
Abstract
Objective To detect CEA expression in peripheral blood of non-small lung cancer(NSCLC) patients and discuss the possibility of indicating NSCLC micrometastases by it.Methods The expression of CEA mRNA was analyzed by RT-PCR in 48 NSCLC in peripheral blood,compared with 15 patients with benign lung disease(BLD)and 10 healthy volunteers.Results The positive expression rate of CEA mRNA was significantly higher in NSCLC than in those of BLD and healthy volunteers(P0.01).The expression rate of CEA mRNA was 27.8%,83.3%,61.5%,100% in peripheral blood with non-small cell lung cancer of TNM stageⅠ~Ⅳrespectively.The positive expression of CEA was closely related with the clinical staging and lymph node metastasis(P0.05),but not related to pathological type and tumor cell differentiation(P0.05).Conclusion Expressions of CEA mRNA in peripheral blood can be used as a valuable biomarker for diagnosis of micrometastasis in patients with NSCLC.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To detect CEA expression in peripheral blood of non-small lung cancer(NSCLC) patients and discuss the possibility of indicating NSCLC micrometastases by it.Methods The expression of CEA mRNA was analyzed by RT-PCR in 48 NSCLC in peripheral blood,compared with 15 patients with benign lung disease(BLD)and 10 healthy volunteers.Results The positive expression rate of CEA mRNA was significantly higher in NSCLC than in those of BLD and healthy volunteers(P0.01).The expression rate of CEA mRNA was 27.8%,83.3%,61.5%,100% in peripheral blood with non-small cell lung cancer of TNM stageⅠ~Ⅳrespectively.The positive expression of CEA was closely related with the clinical staging and lymph node metastasis(P0.05),but not related to pathological type and tumor cell differentiation(P0.05).Conclusion Expressions of CEA mRNA in peripheral blood can be used as a valuable biomarker for diagnosis of micrometastasis in patients with NSCLC.
Key concepts: Micrometastasis, Medicine, Lung cancer, Stage (stratigraphy), Peripheral blood, Clinical significance, Pathological, Oncology